Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Novel Frontline Approaches Induce Deep, Durable Responses in Multiple Myeloma

Jessica Hergert
Published: Tuesday, Sep 03, 2019

Michael A. Rosenzweig, MD, MS, assistant clinical professor of Hematology and Hematopoietic Cell Transplantation and hematologist/oncologist at City of Hope

Michael A. Rosenzweig, MD, MS
Utilizing the oncology standard that "more is better," frontline treatment options for patients with multiple myeloma are expanding to include more novel agents and different combinations in order to obtain deeper responses, explained Michael A. Rosenzweig, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication